Skip to content
Screener

uniQure QURE Other income, net (Note 6)

Other income, net (Note 6) at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
-$15.04M-140%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
-$31K-338%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$1.61M+126%
Opus Genetics logo
Opus GeneticsIRD
$844K+179%
Arvinas logo
ArvinasARVN
-$100K
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$1M-50.0%

Segments

By segment

See full
Single Reportable-$5.39M-843%

Other financials

Income statement

See full
Revenue$5.8M+11.0%
Gross profit$5.5M+19.2%
Operating income-$52.2M-19.0%
Net income-$81.1M-115%
EPS (diluted)-$1.22-76.8%

Balance sheet

See full
Cash & equivalents$413.0M+62.8%
Total debt$62.8M-5.8%
Total equity$324.1M+8,195%
Total assets$985.1M+68.4%

Cash flow

See full
Operating cash flow-$28.6M+28.4%
CapEx$472.0K+81.5%
Free cash flow-$29.0M+27.7%

Valuation

See full
Market cap$3.15B+325%
Enterprise value$2.8B+406%
P/S168.5×+117×

Profitability

See full
Gross margin92.5%+4.6pp
Operating margin-1,071.5%-90.6pp
Net margin-1,350.7%-35.3pp
FCF margin-864.7%-194pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.2×
Current ratio10×0.0×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The source filing: uniQure’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 7:17 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-087815
Line itemThree months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025
Interest income5,0513,52410,2807,651
Interest expense(14,366)(15,591)(28,397)(30,700)
Foreign currency (losses) / gains, net(1,730)18,638(4,024)25,810
Other non-operating (losses), net(15,970)(12,201)
Loss before income tax expense$(79,218)$(37,294)$(132,265)$(80,435)
Income tax expense(1,841)(425)(2,329)(921)
Net loss$(81,059)$(37,719)$(134,594)$(81,356)
Other comprehensive loss:

Item 1.Financial Statements

FAQ

What is uniQure's other income, net (note 6)?
uniQure (QURE) reported other income, net (note 6) of -$15.97M in Q2 2026.
What does other income, net (note 6) mean?
This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.

Ask your AI about uniQure's other income, net (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude